| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB11
|
ATP-binding cassette, sub-family B (MDR/TAP), member 11
|
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ACAN
|
aggrecan
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACVR1
|
activin A receptor, type I
|
|
ACVRL1
|
activin A receptor type II-like 1
|
|
ADA
|
adenosine deaminase
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADRA2C
|
adrenoceptor alpha 2C
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AFP
|
alpha-fetoprotein
|
|
AGK
|
acylglycerol kinase
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AHCY
|
adenosylhomocysteinase
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
ALX3
|
ALX homeobox 3
|
|
AMH
|
anti-Mullerian hormone
|
|
ANGPT2
|
angiopoietin 2
|
|
ANOS1
|
anosmin 1
|
|
ANXA1
|
annexin A1
|
|
ANXA5
|
annexin A5
|
|
ANXA7
|
annexin A7
|
|
APC
|
adenomatous polyposis coli
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APOA5
|
apolipoprotein A-V
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
ARMC5
|
armadillo repeat containing 5
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
|
ASPM
|
asp (abnormal spindle) homolog, microcephaly associated (Drosophila)
|
|
ASPRV1
|
aspartic peptidase, retroviral-like 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
|
ATP8B1
|
ATPase, aminophospholipid transporter, class I, type 8B, member 1
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
|
AURKA
|
aurora kinase A
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BARD1
|
BRCA1 associated RING domain 1
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BEST1
|
bestrophin 1
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BST1
|
bone marrow stromal cell antigen 1
|
|
C9ORF72
|
chromosome 9 open reading frame 72
|
|
CA9
|
carbonic anhydrase IX
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBS
|
cystathionine-beta-synthase
|
|
CCAR2
|
cell cycle and apoptosis regulator 2
|
|
CCL3L1
|
chemokine (C-C motif) ligand 3-like 1
|
|
CCM2
|
cerebral cavernous malformation 2
|
|
CCND1
|
cyclin D1
|
|
CCNY
|
cyclin Y
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
|
CD14
|
CD14 molecule
|
|
CD4
|
CD4 molecule
|
|
CD40LG
|
CD40 ligand
|
|
CD5
|
CD5 molecule
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CD69
|
CD69 molecule
|
|
CDA
|
cytidine deaminase
|
|
CDC73
|
cell division cycle 73
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH17
|
cadherin 17, LI cadherin (liver-intestine)
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CDKAL1
|
CDK5 regulatory subunit associated protein 1-like 1
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDKN2B-AS1
|
CDKN2B antisense RNA 1
|
|
CDX2
|
caudal type homeobox 2
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEACAM19
|
carcinoembryonic antigen-related cell adhesion molecule 19
|
|
CFH
|
complement factor H
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CGRRF1
|
cell growth regulator with ring finger domain 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CLCN1
|
chloride channel, voltage-sensitive 1
|
|
CLDN7
|
claudin 7
|
|
CLSPN
|
claspin
|
|
CLU
|
clusterin
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COL8A2
|
collagen, type VIII, alpha 2
|
|
COMT
|
catechol-O-methyltransferase
|
|
CORO1A
|
coronin, actin binding protein, 1A
|
|
COX10
|
COX10 heme A:farnesyltransferase cytochrome c oxidase assembly factor
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRYBB2
|
crystallin, beta B2
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSNK1E
|
casein kinase 1, epsilon
|
|
CSPP1
|
centrosome and spindle pole associated protein 1
|
|
CST3
|
cystatin C
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP3A
|
cytochrome P450, family 3, subfamily A
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
CYP4F2
|
cytochrome P450, family 4, subfamily F, polypeptide 2
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
DAXX
|
death-domain associated protein
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DLK1
|
delta-like 1 homolog (Drosophila)
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DRD3
|
dopamine receptor D3
|
|
EDN1
|
endothelin 1
|
|
EGFR
|
epidermal growth factor receptor
|
|
EML4
|
echinoderm microtubule associated protein like 4
|
|
ENG
|
endoglin
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
EZR
|
ezrin
|
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
|
F2
|
coagulation factor II (thrombin)
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FCER1A
|
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
|
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha
|
|
FCN2
|
ficolin (collagen/fibrinogen domain containing lectin) 2
|
|
FECH
|
ferrochelatase
|
|
FGB
|
fibrinogen beta chain
|
|
FGF10
|
fibroblast growth factor 10
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FIG4
|
FIG4 phosphoinositide 5-phosphatase
|
|
FKBP5
|
FK506 binding protein 5
|
|
FLCN
|
folliculin
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FN1
|
fibronectin 1
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B
|
|
FOXF1
|
forkhead box F1
|
|
FOXP2
|
forkhead box P2
|
|
FOXP3
|
forkhead box P3
|
|
FRG2
|
FSHD region gene 2
|
|
FTO
|
fat mass and obesity associated
|
|
FZD4
|
frizzled class receptor 4
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GADD45G
|
growth arrest and DNA-damage-inducible, gamma
|
|
GALNT12
|
polypeptide N-acetylgalactosaminyltransferase 12
|
|
GALNT13
|
polypeptide N-acetylgalactosaminyltransferase 13
|
|
GALNT3
|
polypeptide N-acetylgalactosaminyltransferase 3
|
|
GALNT8
|
polypeptide N-acetylgalactosaminyltransferase 8
|
|
GAS7
|
growth arrest-specific 7
|
|
GATA3
|
GATA binding protein 3
|
|
GBA
|
glucosidase, beta, acid
|
|
GBE1
|
glucan (1,4-alpha-), branching enzyme 1
|
|
GBP1
|
guanylate binding protein 1, interferon-inducible
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GDF15
|
growth differentiation factor 15
|
|
GDF2
|
growth differentiation factor 2
|
|
GDF6
|
growth differentiation factor 6
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GH1
|
growth hormone 1
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GJB4
|
gap junction protein, beta 4, 30.3kDa
|
|
GJB6
|
gap junction protein, beta 6, 30kDa
|
|
GLCCI1
|
glucocorticoid induced 1
|
|
GOLM1
|
golgi membrane protein 1
|
|
GOSR2
|
golgi SNAP receptor complex member 2
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GPR68
|
G protein-coupled receptor 68
|
|
GRN
|
granulin
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
HABP2
|
hyaluronan binding protein 2
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HCN2
|
hyperpolarization activated cyclic nucleotide gated potassium channel 2
|
|
HFE
|
hemochromatosis
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HP
|
haptoglobin
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSD17B4
|
hydroxysteroid (17-beta) dehydrogenase 4
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
HULC
|
hepatocellular carcinoma up-regulated long non-coding RNA
|
|
IAPP
|
islet amyloid polypeptide
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
IDE
|
insulin-degrading enzyme
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IDUA
|
iduronidase, alpha-L-
|
|
IER3
|
immediate early response 3
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFN1@
|
interferon, type 1, cluster
|
|
IFNG
|
interferon, gamma
|
|
IFNL3
|
interferon, lambda 3
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGHV3-21
|
immunoglobulin heavy variable 3-21
|
|
IKBKE
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL10
|
interleukin 10
|
|
IL13
|
interleukin 13
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL6
|
interleukin 6
|
|
INHBA
|
inhibin, beta A
|
|
INS
|
insulin
|
|
IRAK3
|
interleukin-1 receptor-associated kinase 3
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
JAK2
|
Janus kinase 2
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNQ1OT1
|
KCNQ1 opposite strand/antisense transcript 1 (non-protein coding)
|
|
KDR
|
kinase insert domain receptor
|
|
KIAA1524
|
KIAA1524
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF9
|
Kruppel-like factor 9
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2D
|
lysine (K)-specific methyltransferase 2D
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRIT1
|
KRIT1, ankyrin repeat containing
|
|
KRT14
|
keratin 14, type I
|
|
KRT16
|
keratin 16, type I
|
|
KRT5
|
keratin 5, type II
|
|
LAMP2
|
lysosomal-associated membrane protein 2
|
|
LAPTM4B
|
lysosomal protein transmembrane 4 beta
|
|
LBP
|
lipopolysaccharide binding protein
|
|
LCN2
|
lipocalin 2
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LIPH
|
lipase, member H
|
|
LMNA
|
lamin A/C
|
|
LMNB1
|
lamin B1
|
|
LOX
|
lysyl oxidase
|
|
LPAR6
|
lysophosphatidic acid receptor 6
|
|
LRIG1
|
leucine-rich repeats and immunoglobulin-like domains 1
|
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
MAOA
|
monoamine oxidase A
|
|
MAP4
|
microtubule-associated protein 4
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPT
|
microtubule-associated protein tau
|
|
MASP2
|
mannan-binding lectin serine peptidase 2
|
|
MATN2
|
matrilin 2
|
|
MBD2
|
methyl-CpG binding domain protein 2
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MBOAT4
|
membrane bound O-acyltransferase domain containing 4
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MEG3
|
maternally expressed 3 (non-protein coding)
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGP
|
matrix Gla protein
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR141
|
microRNA 141
|
|
MIR143
|
microRNA 143
|
|
MIR145
|
microRNA 145
|
|
MIR148A
|
microRNA 148a
|
|
MIR21
|
microRNA 21
|
|
MIR224
|
microRNA 224
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLF1
|
myeloid leukemia factor 1
|
|
MMACHC
|
methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MOG
|
myelin oligodendrocyte glycoprotein
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MSH2
|
mutS homolog 2
|
|
MSLN
|
mesothelin
|
|
MTA1
|
metastasis associated 1
|
|
MTDH
|
metadherin
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYH7
|
myosin, heavy chain 7, cardiac muscle, beta
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYOT
|
myotilin
|
|
NACC1
|
nucleus accumbens associated 1, BEN and BTB (POZ) domain containing
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NCR3
|
natural cytotoxicity triggering receptor 3
|
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase
|
|
NEFL
|
neurofilament, light polypeptide
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
NIPBL
|
Nipped-B homolog (Drosophila)
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH3
|
notch 3
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPB
|
natriuretic peptide B
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NRXN3
|
neurexin 3
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OSM
|
oncostatin M
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PCA3
|
prostate cancer associated 3 (non-protein coding)
|
|
PCSK9
|
proprotein convertase subtilisin/kexin type 9
|
|
PDCD10
|
programmed cell death 10
|
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PEBP4
|
phosphatidylethanolamine-binding protein 4
|
|
PEX7
|
peroxisomal biogenesis factor 7
|
|
PHF8
|
PHD finger protein 8
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PLCE1
|
phospholipase C, epsilon 1
|
|
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5
|
|
PLK2
|
polo-like kinase 2
|
|
PML
|
promyelocytic leukemia
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
POLDIP2
|
polymerase (DNA-directed), delta interacting protein 2
|
|
POMGNT1
|
protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)
|
|
PON1
|
paraoxonase 1
|
|
POR
|
P450 (cytochrome) oxidoreductase
|
|
POU2F1
|
POU class 2 homeobox 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCG
|
protein kinase C, gamma
|
|
PRL
|
prolactin
|
|
PSEN1
|
presenilin 1
|
|
PSEN2
|
presenilin 2
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
REN
|
renin
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
ROS1
|
ROS proto-oncogene 1 , receptor tyrosine kinase
|
|
RPGRIP1
|
retinitis pigmentosa GTPase regulator interacting protein 1
|
|
RS1
|
retinoschisin 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
S100B
|
S100 calcium binding protein B
|
|
SCN2A
|
sodium channel, voltage gated, type II alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SELE
|
selectin E
|
|
SEPT9
|
septin 9
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINB3
|
serpin peptidase inhibitor, clade B (ovalbumin), member 3
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SETX
|
senataxin
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SGCE
|
sarcoglycan, epsilon
|
|
SHBG
|
sex hormone-binding globulin
|
|
SHH
|
sonic hedgehog
|
|
SIRT1
|
sirtuin 1
|
|
SLC15A1
|
solute carrier family 15 (oligopeptide transporter), member 1
|
|
SLC15A2
|
solute carrier family 15 (oligopeptide transporter), member 2
|
|
SLC22A5
|
solute carrier family 22 (organic cation/carnitine transporter), member 5
|
|
SLC25A5
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5
|
|
SLC29A2
|
solute carrier family 29 (equilibrative nucleoside transporter), member 2
|
|
SLC34A1
|
solute carrier family 34 (type II sodium/phosphate cotransporter), member 1
|
|
SLC44A2
|
solute carrier family 44 (choline transporter), member 2
|
|
SLC4A1
|
solute carrier family 4 (anion exchanger), member 1 (Diego blood group)
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SMAD4
|
SMAD family member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNAI2
|
snail family zinc finger 2
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SND1
|
staphylococcal nuclease and tudor domain containing 1
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SPDEF
|
SAM pointed domain containing ETS transcription factor
|
|
SPG11
|
spastic paraplegia 11 (autosomal recessive)
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
SRY
|
sex determining region Y
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STMN1
|
stathmin 1
|
|
SUOX
|
sulfite oxidase
|
|
SV2C
|
synaptic vesicle glycoprotein 2C
|
|
TACR1
|
tachykinin receptor 1
|
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TARDBP
|
TAR DNA binding protein
|
|
TBXA2R
|
thromboxane A2 receptor
|
|
TCF4
|
transcription factor 4
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TFPI2
|
tissue factor pathway inhibitor 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGFBR3
|
transforming growth factor, beta receptor III
|
|
THBD
|
thrombomodulin
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIRAP
|
toll-interleukin 1 receptor (TIR) domain containing adaptor protein
|
|
TK2
|
thymidine kinase 2, mitochondrial
|
|
TLR1
|
toll-like receptor 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TM6SF2
|
transmembrane 6 superfamily member 2
|
|
TMCO1
|
transmembrane and coiled-coil domains 1
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP1
|
tumor necrosis factor, alpha-induced protein 1 (endothelial)
|
|
TNFAIP6
|
tumor necrosis factor, alpha-induced protein 6
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
|
TP53
|
tumor protein p53
|
|
TP53BP1
|
tumor protein p53 binding protein 1
|
|
TP63
|
tumor protein p63
|
|
TPH1
|
tryptophan hydroxylase 1
|
|
TREX1
|
three prime repair exonuclease 1
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
|
TSEN54
|
TSEN54 tRNA splicing endonuclease subunit
|
|
TYMS
|
thymidylate synthetase
|
|
UBE3B
|
ubiquitin protein ligase E3B
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
ULK1
|
unc-51 like autophagy activating kinase 1
|
|
UNC93B1
|
unc-93 homolog B1 (C. elegans)
|
|
USB1
|
U6 snRNA biogenesis 1
|
|
VASH1
|
vasohibin 1
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VCL
|
vinculin
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VWF
|
von Willebrand factor
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
|
WNT7A
|
wingless-type MMTV integration site family, member 7A
|
|
WT1
|
Wilms tumor 1
|
|
ZBTB33
|
zinc finger and BTB domain containing 33
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
|
ZFYVE26
|
zinc finger, FYVE domain containing 26
|
|
ZNF652
|
zinc finger protein 652
|
